TGF-beta mRNA expression in the renal pelvis after experimental and clinical ureteropelvic junction obstruction

被引:47
作者
Seremetis, GM
Maizels, M
机构
[1] CHILDRENS MEM HOSP,DIV UROL,CHICAGO,IL 60614
[2] NORTHWESTERN UNIV,SCH MED,DEPT UROL,CHICAGO,IL 60611
关键词
growth substances; hydronephrosis; polymerase chain reaction;
D O I
10.1016/S0022-5347(01)66013-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The renal parenchymal expression of transforming growth factor-beta (TGF-beta) is increased in experimental obstructive uropathy. To better understand the pathophysiology of hydronephrosis, we pursued this observation by determining if the expression of TGF-beta is also increased in the obstructed renal pelvis. Materials and Methods: The expression of TGF-beta mRNA was evaluated in experimental and clinical ureteropelvic junction obstruction by reverse transcriptase polymerase chain reaction (RT-PCR). Southern blot analysis with labeled human cDNA probes for TGF-beta was then done to verify the results. Results: Experimentally, pelves subjected to ureteral constriction showed significantly higher TGF-beta mRNA expression than normals. After reversal of obstruction, the expression of TGF-beta remained significantly higher than normals but was not different from pelves with ongoing obstruction. Clinically, there was a significantly higher level of TGF-beta mRNA expression in obstructed pelves than in nonobstructed ureters. High levels of TGF-beta mRNA expression correlated significantly with good clinical outcome, good renal function, muscle hypertrophy and acute onset of obstruction. Conclusions: There is increased TGF-beta mRNA expression in the renal pelvis following clinical and experimental ureteropelvic junction obstruction. These data implicate TGF-beta in the adaptive molecular responses that increase muscle and collagen elaboration seen in hydronephrosis.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 36 条
[1]  
Ausubel F.M., 1992, CURRENT PROTOCOLS MO
[2]   THE CELL BIOLOGY OF TRANSFORMING GROWTH-FACTOR-BETA [J].
BARNARD, JA ;
LYONS, RM ;
MOSES, HL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) :79-87
[3]  
BAUER SB, 1992, ANOMALIES URETEROPEL, P1393
[4]   RESPONSE OF THE NEWBORN URETEROPELVIC JUNCTION COMPLEX TO INDUCED AND LATER REVERSED PARTIAL URETERAL OBSTRUCTION IN THE RABBIT MODEL [J].
CHENG, EY ;
MAIZELS, M ;
CHOU, P ;
HARTANTO, V ;
SHAPIRO, E .
JOURNAL OF UROLOGY, 1993, 150 (02) :782-789
[5]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]  
CONWAY J, 1992, J NUCL MED, V33, P2047
[7]   HUMAN TRANSFORMING GROWTH FACTOR-BETA COMPLEMENTARY-DNA SEQUENCE AND EXPRESSION IN NORMAL AND TRANSFORMED-CELLS [J].
DERYNCK, R ;
JARRETT, JA ;
CHEN, EY ;
EATON, DH ;
BELL, JR ;
ASSOIAN, RK ;
ROBERTS, AB ;
SPORN, MB ;
GOEDDEL, DV .
NATURE, 1985, 316 (6030) :701-705
[8]   GROWTH-FACTORS AND METANEPHROGENESIS [J].
HAMMERMAN, MR ;
ROGERS, SA ;
RYAN, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (04) :F523-F532
[9]  
HORIKOSHI T, 1992, CANCER RES, V52, P108
[10]  
Kawasaki E. S., 1990, PCR PROTOCOLS GUIDE, P21